Skip to content
Catalyst

PapersPMID:41245414

The effect of long-term magnesium intake on inflammatory markers in patients with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials.

Frontiers in nutrition2025The record ↗

  1. Finding, moderate evidenceno difference foundTumour necrosis factor alpha concentration

No finding here moved its endpoint.

What did not

1 findingHow to read these marks →
  • “For inflammatory parameters with fewer than 3 RCTs, magnesium supplementation showed no significant effects on serum IL-6 or tumor necrosis factor-alpha levels.”
    Study
    meta-analysis
    Population
    adults with metabolic syndrome or related insulin-resistant/diabetic conditions, oral magnesium supplementation for at least 2 months versus placebo (meta-analysis, fewer than 3 pooled RCTs for this analyte)

Study record

Design
meta-analysis
Species
human
Population
adults with metabolic syndrome
Participants
444
Comparator
placebo
Duration
not reported
Endpoints measured
11